|

AUCD Community Inclusion

AUCD’s Community Inclusion Team supports the University Centers for Excellence in Developmental Disabilities (UCEDD) Network in partnership with the Administration for Community Living.

Learn More
|

AUCD Maternal and Child Health Engagement

AUCD’s Maternal and Child Health Engagement supports the Autism CARES Programs, including LEND and DBP Programs.

Learn More
|

AUCD Public Health

AUCD’s Public Health Team works to create health promotion and public health efforts that include people with disabilities.

Learn More
|

AUCD Emerging Leaders Community

AUCD Emerging Leaders are a part of a community that includes trainees, early career professionals, self-advocates, and family members from AUCD member Centers and Programs.

Learn More

Donate

Product

LEND: Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline

Center:

OR-Oregon Institute on Development & Disability, UCEDD/LEND

Fiscal Year:

2020

Contact Information:

Kristin Knight
[email protected]
503-494-2061

Product Description:

Systematic review of randomized trials for the prevention of cisplatin-induced ototoxicity and recommended clinical practice guidelines. The panel made a strong recommendation for the use of sodium thiosulfate in non-metastatic hepatoblastoma, a weak recommendation for administration in other non-metastatic cancers, and a weak recommendation against its routine use in metastatic cancers.

Keyword(s):

cisplatin, ototoxicity, children, cancer, prevention

Product/Publication Type(s):

Peer-reviewed publications in scholarly journals Published/In Press

Target Audience:

Professionals, Policymakers

Alternative Format:

To Obtain Copies (URL or Email):

[email protected]

COVID-19 Related Data:

N/A

1100 Wayne Avenue, Suite 1000 Silver Spring, MD 20910